{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:35:18Z","timestamp":1788784518985,"version":"build-2803163510"},"reference-count":68,"publisher":"European Respiratory Society (ERS)","issue":"156","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,6,4]]},"published-print":{"date-parts":[[2020,6,30]]},"abstract":"<jats:p>Acute respiratory distress syndrome (ARDS) remains a significant source of mortality in critically ill patients. Characterised by acute, widespread alveolar inflammation and pulmonary oedema, its pathophysiological heterogeneity has meant that targeted treatments have remained elusive. Metabolomic analysis has made initial steps in characterising the underlying metabolic derangements of ARDS as an indicator of phenotypical class and has identified mitochondrial dysfunction as a potential therapeutic target. Mesenchymal stem cells and their derived extracellular vesicles have shown significant promise as potential therapies in delivering mitochondria in order to redivert metabolism onto physiological pathways.<\/jats:p>","DOI":"10.1183\/16000617.0114-2020","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T13:20:34Z","timestamp":1593782434000},"page":"200114","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome"],"prefix":"10.1183","volume":"29","author":[{"given":"Matthew John","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2380-5069","authenticated-orcid":false,"given":"Anna D.","family":"Krasnodembskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"2024102403462472000_29.156.200114.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1608077"},{"key":"2024102403462472000_29.156.200114.2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCC.0000000000000571","article-title":"Phenotypes in acute respiratory distress syndrome: moving towards precision medicine","volume":"25","author":"Sinha","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2024102403462472000_29.156.200114.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02197-2017"},{"key":"2024102403462472000_29.156.200114.4","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00073.2014"},{"key":"2024102403462472000_29.156.200114.5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chest.2019.09.028","article-title":"Plasma mitochondrial DNA levels are associated with ARDS in trauma and sepsis patients","volume":"157","author":"Faust","year":"2020","journal-title":"Chest"},{"key":"2024102403462472000_29.156.200114.6","doi-asserted-by":"publisher","DOI":"10.1128\/JB.180.19.5109-5116.1998"},{"key":"2024102403462472000_29.156.200114.7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fimmu.2016.00044","article-title":"Metabolomics and its application to acute lung diseases","volume":"7","author":"Stringer","year":"2016","journal-title":"Front Immunol"},{"key":"2024102403462472000_29.156.200114.8","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00376.2013"},{"key":"2024102403462472000_29.156.200114.9","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41598-019-39017-4","article-title":"Distinct metabolic endotype mirroring acute respiratory distress syndrome (ARDS) subphenotype and its heterogeneous biology","volume":"9","author":"Viswan","year":"2019","journal-title":"Sci Rep"},{"key":"2024102403462472000_29.156.200114.10","doi-asserted-by":"crossref","first-page":"L526","DOI":"10.1152\/ajplung.00074.2018","article-title":"Evolution of ARDS biomarkers: will metabolomics be the answer?","volume":"315","author":"Metwaly","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2024102403462472000_29.156.200114.11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/SHK.0000000000001099","article-title":"Metabolomic profile of ARDS by nuclear magnetic resonance spectroscopy in patients with H1N1 influenza virus pneumonia","volume":"50","author":"Izquierdo-Garcia","year":"2018","journal-title":"Shock"},{"key":"2024102403462472000_29.156.200114.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0474CI"},{"key":"2024102403462472000_29.156.200114.13","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00231.2010"},{"key":"2024102403462472000_29.156.200114.14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13054-019-2456-z","article-title":"Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors","volume":"23","author":"Liu","year":"2019","journal-title":"Crit Care"},{"key":"2024102403462472000_29.156.200114.15","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050589"},{"key":"2024102403462472000_29.156.200114.16","doi-asserted-by":"publisher","DOI":"10.1021\/pr4007624"},{"key":"2024102403462472000_29.156.200114.17","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00438.2016"},{"key":"2024102403462472000_29.156.200114.18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102403462472000_29.156.200114.19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2024102403462472000_29.156.200114.20","doi-asserted-by":"publisher","DOI":"10.1177\/01486071050290S1S70"},{"key":"2024102403462472000_29.156.200114.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2013.11.017"},{"key":"2024102403462472000_29.156.200114.22","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209719"},{"key":"2024102403462472000_29.156.200114.23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1164\/rccm.201809-1808OC","article-title":"Understanding heterogeneity in biologic phenotypes of acute respiratory distress syndrome by leukocyte expression profiles","volume":"200","author":"Bos","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403462472000_29.156.200114.24","doi-asserted-by":"crossref","first-page":"e0187545","DOI":"10.1371\/journal.pone.0187545","article-title":"Metabolomics based predictive biomarker model of ARDS: a systemic measure of clinical hypoxemia","volume":"12","author":"Viswan","year":"2017","journal-title":"PLoS One"},{"key":"2024102403462472000_29.156.200114.25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00134-019-05634-w","article-title":"Metabolomic profile of acute respiratory distress syndrome of different etiologies","volume":"45","author":"Izquierdo-Garc\u00eda","year":"2019","journal-title":"Intensive Care Med"},{"key":"2024102403462472000_29.156.200114.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201003-0326OC"},{"key":"2024102403462472000_29.156.200114.27","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-19"},{"key":"2024102403462472000_29.156.200114.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09459-X"},{"key":"2024102403462472000_29.156.200114.29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.chest.2019.08.2182","article-title":"Mitochondria and critical illness","volume":"157","author":"Supinski","year":"2020","journal-title":"Chest"},{"key":"2024102403462472000_29.156.200114.30","first-page":"37","article-title":"Mitochondrial bioenergetics and pulmonary dysfunction: current progress and future directions","volume":"34","author":"Ten","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"2024102403462472000_29.156.200114.31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7631"},{"key":"2024102403462472000_29.156.200114.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.124.3215.267"},{"key":"2024102403462472000_29.156.200114.33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.403"},{"key":"2024102403462472000_29.156.200114.34","doi-asserted-by":"crossref","first-page":"e1319","DOI":"10.1097\/MD.0000000000001319","article-title":"Glutamine supplementation in intensive care patients: a meta-analysis of randomized clinical trials","volume":"94","author":"Oldani","year":"2015","journal-title":"Medicine"},{"key":"2024102403462472000_29.156.200114.35","first-page":"CD012041","article-title":"Immunonutrition for acute respiratory distress syndrome (ARDS) in adults","volume":"1","author":"Dushianthan","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102403462472000_29.156.200114.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2009.11.010"},{"key":"2024102403462472000_29.156.200114.37","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.21"},{"key":"2024102403462472000_29.156.200114.38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1484"},{"key":"2024102403462472000_29.156.200114.39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001577"},{"key":"2024102403462472000_29.156.200114.40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.injury.2017.01.009","article-title":"Plasma mitochondrial DNA levels were independently associated with lung injury in elderly hip fracture patients","volume":"48","author":"Zhang","year":"2017","journal-title":"Injury"},{"key":"2024102403462472000_29.156.200114.41","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0429-1"},{"key":"2024102403462472000_29.156.200114.42","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150025"},{"key":"2024102403462472000_29.156.200114.43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S2213-2600(14)70217-6","article-title":"Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis","volume":"2","author":"Walter","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102403462472000_29.156.200114.44","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201206-0990OC"},{"key":"2024102403462472000_29.156.200114.45","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front Immunol"},{"key":"2024102403462472000_29.156.200114.46","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3028"},{"key":"2024102403462472000_29.156.200114.47","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093133"},{"key":"2024102403462472000_29.156.200114.48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/sctm.19-0205","article-title":"Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome","volume":"9","author":"Abraham","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"2024102403462472000_29.156.200114.49","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2922"},{"key":"2024102403462472000_29.156.200114.50","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2736"},{"key":"2024102403462472000_29.156.200114.51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510511103"},{"key":"2024102403462472000_29.156.200114.52","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0529OC"},{"key":"2024102403462472000_29.156.200114.53","doi-asserted-by":"publisher","DOI":"10.1002\/embj.201386030"},{"key":"2024102403462472000_29.156.200114.54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9472"},{"key":"2024102403462472000_29.156.200114.55","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0170OC"},{"key":"2024102403462472000_29.156.200114.56","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2372"},{"key":"2024102403462472000_29.156.200114.57","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3389\/fphys.2018.01572","article-title":"Mesenchymal stem cells shift mitochondrial dynamics and enhance oxidative phosphorylation in recipient cells","volume":"9","author":"Newell","year":"2018","journal-title":"Front Physiol"},{"key":"2024102403462472000_29.156.200114.58","doi-asserted-by":"publisher","DOI":"10.1007\/s11745-997-0118-9"},{"key":"2024102403462472000_29.156.200114.59","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3390\/ijms20102406","article-title":"Genetic stability of mesenchymal stromal cells for regenerative medicine applications: a fundamental biosafety aspect","volume":"20","author":"Neri","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024102403462472000_29.156.200114.60","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1096\/fj.201802056R","article-title":"Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair","volume":"33","author":"Fergie","year":"2019","journal-title":"FASEB J"},{"issue":"Suppl. 9","key":"2024102403462472000_29.156.200114.61","doi-asserted-by":"crossref","first-page":"S1329","DOI":"10.21037\/jtd.2019.04.22","article-title":"Cell therapy for acute respiratory distress syndrome patients: the START study","volume":"11","author":"Cruz","year":"2019","journal-title":"J Thorac Dis"},{"key":"2024102403462472000_29.156.200114.62","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-39"},{"key":"2024102403462472000_29.156.200114.63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102403462472000_29.156.200114.64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102403462472000_29.156.200114.65","first-page":"A7353","article-title":"Primary analysis of a phase 1\/2 study to assess Multistem cell therapy, a regenerative advanced therapy medicinal product (ATMP), in acute respiratory distress syndrome (MUST-ARDS)","volume":"199","author":"Bellingan","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102403462472000_29.156.200114.66","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00858-2020"},{"key":"2024102403462472000_29.156.200114.67","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"2024102403462472000_29.156.200114.68","first-page":"E005","article-title":"Advances in the research of cytokine storm mechanism induced by corona virus disease 2019 and the corresponding immunotherapies","volume":"36","author":"Chen","year":"2020","journal-title":"Zhonghua Shao Shang Za Zhi"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0114-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:01:49Z","timestamp":1740373309000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0114-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":68,"journal-issue":{"issue":"156","published-online":{"date-parts":[[2020,7,3]]},"published-print":{"date-parts":[[2020,6,30]]}},"alternative-id":["10.1183\/16000617.0114-2020"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0114-2020","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]}}}